Exponent (EXPO) grants 9,500 restricted stock units to group VP
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Exponent Inc reported that Group Vice President Maureen T. F. Reitman received a grant of 9,500 restricted stock units (RSUs) on March 13, 2026. Each RSU represents a right to receive one share of Exponent common stock, giving her 9,500 RSUs outstanding after this award. These units vest into common shares based on the company’s terms, with an exercise and expiration date in March 2030, and were granted at no cash cost to her as part of equity compensation.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Reitman Maureen T. F.
Role
Group Vice President
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units | 9,500 | $0.00 | -- |
Holdings After Transaction:
Restricted Stock Units — 9,500 shares (Direct)
Footnotes (1)
- 1-for-1. Not applicable.
FAQ
What insider transaction did Exponent (EXPO) report for Maureen Reitman?
Exponent reported that Group Vice President Maureen T. F. Reitman received 9,500 restricted stock units. The RSUs were granted as equity compensation, giving her rights to future common shares rather than involving any open-market stock purchase or sale.
How many restricted stock units did the Exponent (EXPO) executive receive?
Maureen T. F. Reitman received 9,500 restricted stock units. After this grant, her total reported RSU holdings from this award are 9,500 units, each linked on a one-for-one basis to Exponent common stock under the company’s equity compensation arrangements.
Does the Exponent (EXPO) Form 4 show a stock purchase or sale?
The Form 4 shows an acquisition of 9,500 restricted stock units as a grant, not an open-market purchase or sale. It reflects compensation in stock-based units, with no transaction price paid by the executive for the award.
What does the 1-for-1 footnote mean in the Exponent (EXPO) filing?
The 1-for-1 footnote indicates each restricted stock unit corresponds to one share of Exponent common stock. This means the 9,500 RSUs granted could convert into 9,500 common shares, subject to vesting and other terms in the company’s equity plan.
When do the granted Exponent (EXPO) restricted stock units expire or settle?
The filing shows both an exercise date and an expiration date in March 2030. This suggests the 9,500 restricted stock units are designed to settle into common shares by that time, subject to the vesting and plan conditions described in the company’s arrangements.